Apotex Makes 2nd Acquisition in Europe by Purchasing Lareq Pharma of Spain
Lareq, founded in 1984 and dedicated to generics since 1996, is a mid-sized generic pharmaceutical company. With 12 generic registrations, several pending near-term launches and products in development, Lareq is the 13th largest player in the retail pharmacy generics segment, according to the company. It benefits from strong brand recognition amongst pharmacists, and a nation-wide sales force that reaches Spain's retail pharmacies.
Just recently, Apotex announced the acquisition of Topgen of Belgium from the Zambon Group. "The acquisitions in Belgium and Spain, as well as our new affiliate in Turkey, are clear signals of our commitment to growth outside Canada and the US" continues Andrew Kay.
Other news from the department business & finance
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.